Anti-Mouse/Human CD11b Antibody (M1/70)
Based on 1 publication(s) in Google Scholar
Anti-Mouse/Human CD11b Antibody (M1/70) is an anti-mouse CD11b IgG2b monoclonal antibody. Anti-Mouse/Human CD11b Antibody (M1/70) can significantly inhibit the adhesion between dendritic cells (DCs) and platelets. Anti-Mouse/Human CD11b Antibody (M1/70) can kill ovarian cancer cells and inhibit their migration. Anti-Mouse/Human CD11b Antibody (M1/70) can alleviate renal fibrosis and inflammation. Anti-Mouse/Human CD11b Antibody (M1/70) can be used for researches on inflammation conditions and cancer such as ischemia-reperfusion injury (IRI), thrombotic inflammatory conditions and ovarian cancer.
For research use only. We do not sell to patients.
- Purity : 95.00%
- Molecular Weight:150 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Anti-Mouse/Human CD11b Antibody (M1/70)
More
Biological Activity
Description
Isotype
Rat IgG2b kappa
Recommend Isotype Controls
Species Reactivity
Mouse
In Vitro
Anti-Mouse/Human CD11b Antibody (M1/70) (10 μg/mL, 30 min) significantly inhibits the adhesion of bone marrow-derived dendritic cells (bmDCs) to fixed platelets[2].
Anti-Mouse/Human CD11b Antibody (M1/70) (5-10 μg/mL, 24 h) significantly kills epithelial ovarian cancer (EOC) cells[3].
Anti-Mouse/Human CD11b Antibody (M1/70) (5-15 μg/mL, 36 h) dose dependently inhibits cell migration in SKOV-3 and MDAH-2774 cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A2780, MDAH-2774, SKOV-3, OV90, TOV-21G, TOV112D and OV433 cells
-
Concentration:5 and 10 μg/mL
-
Incubation Time:24 h
-
Result:Significantly killed EOC cells with various efficacies ranging from 27 % to 96 %.
-
Cell Line:SKOV-3 and MDAH-2774 cells
-
Concentration:5, 10 and 15 μg/mL
-
Incubation Time:36 h
-
Result:Delayed closure until 28 hours at 10 μg/mL, inhibited 50 % migration at 15 μg/mL.
In Vivo
Anti-Mouse/Human CD11b Antibody (M1/70) (50 μg, i.v., single dose) significantly inhibits the adhesion of DCs to damaged blood vessels in wild type C57BL/6 mice with a carotid artery ligation model[2].
Anti-Mouse/Human CD11b Antibody (M1/70) (60 μg, intratumoral injection, once daily, for 5 days) significantly inhibits tumor growth in female anthymic Nude-Foxn1nu mice bearing SKOV-3 tumors[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male C57BL/6J mice (6-8 weeks) with an IRI model[1]
-
Dosage:2.5 mg/kg
-
Administration:Intraperitoneal injection (i.p.), once every 2 days for 14 days
-
Result:Improved renal fibrosis.
Reduced the the level of Col1a1, Fn1, α-SMA and Col3a1.
Improved the pathological progression of severe acute kidney injury (AKI) to chronic kidney disease (CKD).
-
Animal Model:Wild type C57BL/6 mice with a carotid artery ligation model[2]
-
Dosage:50 μg
-
Administration:Intravenous injection (i.v.), single dose
-
Result:Significantly inhibited the adhesion of DCs to damaged blood vessels.
-
Animal Model:1.5×106 SKOV-3 cells injected female anthymic Nude-Foxn1nu mice[3]
-
Dosage:60 μg
-
Administration:Intratumoral injection, once daily for 5 days
-
Result:Reduced tumor volume by 47 % on day 2, reduced tumor volume by 64.9 % on day 4 and reduced tumor volume by 59.7 % on day 5.
Had no significant systemic toxicity.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Product Image
Application
in vivo CD11b neutralization; ILC2 cell purification; Flow cytometry
Chemical Information
-
Appearance Liquid
-
Molecular Weight 150 kDa
-
Color Colorless to light yellow
-
SMILES
[Anti-Mouse/Human CD11b Antibody (M1/70)]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Protocols
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Monocyte-derived dendritic cell differentiation
Human monocyte-derived dendritic cells are generated by isolating PBMC-derived monocytes and culturing them with GM-CSF plus IL-4, which produces cells with dendritic-cell antigen-presenting properties, reduced monocyte phenotype, and increased dendritic-cell functional readouts such as antigen uptake, allogeneic T-cell stimulation, and expression of markers including HLA-DR, CD80, CD86, CD83, CD1a, or CD209 depending on protocol and maturation state. The main readout is phenotypic and functional differentiation: immature MoDCs are commonly evaluated by loss or reduction of CD14 with acquisition of dendritic-cell markers and antigen uptake capacity, whereas mature MoDCs are evaluated by increased CD83, CD80, CD86, HLA-DR, and T-cell stimulatory function after exposure to maturation stimuli such as TNF-α or a cytokine/PGE2 cocktail.
Purity & Documentation
-
Data Sheet (266 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Zhou H, et al. CD11b deficiency attenuates the ischemia/reperfusion-induced AKI-to-CKD process by regulating macrophage polarization. FASEB J. 2024 Dec 15;38(23):e70216. [Content Brief]
[2]. Nording H, et al. Activated Platelets Upregulate β2 Integrin Mac-1 (CD11b/CD18) on Dendritic Cells, Which Mediates Heterotypic Cell-Cell Interaction. J Immunol. 2022 Apr 1;208(7):1729-1741. [Content Brief]
[3]. Saed GM, et al. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target. Gynecol Oncol. 2018 Mar;148(3):567-575. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)